DOI: 10.26355/eurrev_201911_19370
Treatment of musculoskeletal pain with tapentadol prolonged release
Guest Editors
G. Finco 1, M. Evangelista 2, F. Marinangeli 3
1 Department of Medical Science and Public Health, University of Cagliari,
Cagliari, Italy
2 Department of Anesthesia, Resuscitation and Pain Therapy,
Università Cattolica del Sacro Cuore, Rome, Italy
3 Department of Life, Health and Environmental Sciences,
University of L’Aquila, L’Aquila, Italy
DOI: 10.26355/eurrev_201911_19370
DOI: 10.26355/eurrev_201911_19371
Efficacy and tolerability of tapentadol prolonged release in the elderly and fragile patient: an observational study
DOI: 10.26355/eurrev_201911_19372
Tapentadol prolonged release in fragile geriatric patients > 70 years with chronic severe musculoskeletal pain: an open-label, prospective, observational study
DOI: 10.26355/eurrev_201911_19374
Tapentadol prolonged release and the long-term management of chronic musculoskeletal pain in the elderly – focus on anxiety, depression, cognitive status and life quality: the TaPE study
DOI: 10.26355/eurrev_201911_19375
Tapentadol prolonged release in association with analgesic radiofrequency for the treatment of chronic lumbar radicular pain: an observational, prospective study
DOI: 10.26355/eurrev_201911_19376
Efficacy and tolerability of tapentadol prolonged release during rehabilitation: a prospective, observational study
DOI: 10.26355/eurrev_201911_19377
Efficacy of tapentadol prolonged release for pre- and post-operative low back pain: a prospective observational study
DOI: 10.26355/eurrev_201911_19378
Tapentadol prolonged release in the treatment of musculoskeletal pain: an innovative pharmacological option
DOI: 10.26355/eurrev_201911_19379